...
首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Suggestions from adolescents, young adults, and parents for improving informed consent in phase 1 pediatric oncology trials
【24h】

Suggestions from adolescents, young adults, and parents for improving informed consent in phase 1 pediatric oncology trials

机译:青少年,年轻人和父母的建议,以改善儿童肿瘤学1期试验的知情同意

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND Informed consent for a pediatric oncology phase 1 trial is a delicate process, and is made more complex by the difficulty of the information and the requirement for parental consent, and patient assent when applicable. This analysis identifies suggestions for improving the informed consent process received from parents and adolescent and young adult patients (aged 14 years-21 years) who had the option of participating in a phase 1 pediatric oncology trial. METHODS A total of 57 parents and 20 patients completed interviews as part of a multisite, prospective, descriptive study. These transcribed interviews were studied using established content analysis methods. RESULTS Parent and patient responses contained 220 suggestions and 54 suggestions, respectively. A total of 21 unique suggestions for improvement emerged in 3 main themes: 1) provision of more information; 2) structure and presentation of the informed consent process, and 3) suggestions for physicians conducting the process. Common suggestions included providing more specific information about the trial, allowing more time for decision-making, and using different methods to deliver information. CONCLUSIONS Participants involved in the informed consent process for a phase 1 trial provided specific recommendations to research teams to enhance the process. Physician/investigators should be informed of these recommendations and develop and test interventions incorporating them.
机译:背景技术儿科肿瘤学1期试验的知情同意是一个微妙的过程,并且由于信息的困难和需要父母同意以及患者的同意(如果适用)而变得更加复杂。该分析确定了改善父母,青少年和成年青年患者(年龄在14岁至21岁之间)的知情同意程序的建议,这些患者可以参加1期小儿肿瘤学试验。方法作为多站点,前瞻性和描述性研究的一部分,共有57位父母和20位患者完成了访谈。使用已建立的内容分析方法研究了这些转录的访谈。结果父母和患者的回应分别包含220条建议和54条建议。在3个主要主题中提出了总共21条独特的改进建议:1)提供更多信息; 2)知情同意程序的结构和表示,以及3)进行该程序的医师建议。常见的建议包括提供有关试验的更多具体信息,留出更多时间进行决策以及使用不同的方法来传递信息。结论参与1期临床试验的知情同意程序的参与者向研究团队提供了具体建议,以增强程序。应将这些建议告知内科医师/研究者,并制定和测试包含这些建议的干预措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号